Dr Reddys Laboratories (RDY) EV to EBIT (2009 - 2026)

Dr Reddys Laboratories has reported EV to EBIT for 18 years, with the latest figure at 299.16 in Q2 2026.

• On a quarterly basis, EV to EBIT rose 383.94% year-over-year to 299.16 in Q2 2026; TTM through Jun 2026 was 28.8, a 91.51% increase from a year earlier, with the FY2026 full-year figure at 19.81, up 53.51% from the prior year.
• EV to EBIT was 299.16 for Q2 2026 at Dr Reddys Laboratories, down from 783.31 in the prior quarter.
• The five-year high for EV to EBIT was 783.31 in Q1 2026, with the low at 44.32 in Q1 2023.
• Average EV to EBIT over 5 years is 133.81, with a median of 60.87 recorded in 2022.
• The sharpest annual moves came in 2023 and 2026: EV to EBIT sank 90.11% in 2023, then jumped 1369.06% in 2026.
• Over 5 years, EV to EBIT stood at 63.61 in 2022, then slipped by 12.87% to 55.42 in 2023, then gained by 6.12% to 58.81 in 2024, then gained by 22.39% to 71.98 in 2025, then jumped by 315.61% to 299.16 in 2026.
• The last three EV to EBIT figures came in at 299.16 (Q2 2026), 783.31 (Q1 2026), and 71.98 (Q4 2025), per Business Quant data.